Chr | chr11 |
start | 65497688 |
end | 65506516 |
lncRNA name | MALAT1 |
entrez id | 378938 |
hgnc id | HGNC:29665 |
ensg id | ENSG00000251562 |
refseq id | NR_002819 |
methods | qRT-PCR |
regulated | up-regulated |
function description | all three tagging SNPs (rs3200401, rs619586 and rs7927113) in lncRNA MALAT1 were selected for genotyping in 487BCE patients and 489 cancer-free controls in Chinese Han population, and futher experiment of quantitative real-time (qRT) PCR was conducted to examine the relative expression of MALAT1. The results showed that individuals with genotype AG of rs619586 has a decreased risk of BC in codominant model (OR: 0.684, 95%CI: 0.478-0.979), dominant mode (OR: 0.675, 95%CI: 0.479-0.951) and over-dominant model (OR: 0.692, 95%CI: 0484-0.989). Also, qRT-PCR results revealed that the expression for MALAT1 with AG (0.827??0.490), GG (0.511??0.149) and AG+GG genotypes (0.743??0.447) of rs619586 was significantly lower than that with genotype AA (1.511??0.737). |
pubmed id | 29146194 |
year | 2018 |
title | Association analyses of genetic variants in long non-coding RNA MALAT1 with breast cancer susceptibility and mRNA expression of MALAT1 in Chinese Han population. |
drug | X |
circulating | V |
survival | X |
CopyRight © University of Miami, USA; Harbin Medical University, China